Profound Medical Corp. logo

Profound Medical Corp.

PROF | NASDAQ
Chart Builder DCF Calculator
$6.12
+$0.02 (+0.33%)
Sep 22, 2026, 11:44 AM ET · Market open

Market Data

Market Cap
$221.66M
Enterprise Value
$188.01M
Beta
0.53
Average Volume
86.91K
Shares Outstanding (Diluted)
36.35M
Shares Change YoY
20.95%
Institutional Ownership
45.01%
Exchange
NASDAQ
ISIN
CA74319B5027

Price Performance

Price Change 1M
-10.3%
Price Change 3M
-6.4%
Price Change 6M
4.8%
Price Change YTD
-20.4%
Price Change 1Y
41.9%
Price Change 3Y
-39.1%
Price Change 5Y
-59.3%
1M CAGR (ann.)
-17.7%
1Y CAGR (ann.)
47.7%
5Y CAGR (ann.)
-15.7%
All-Time CAGR
-6.5%

Valuation

PE Ratio
-12.98
Forward PE
N/A
PEG Ratio
-0.15
Forward PEG
0.22
PS Ratio
11.66
Forward PS
5.20
PB Ratio
4.45
P/FCF Ratio
-6.09
P/Adj. FCF Ratio
-5.36
P/OCF Ratio
-6.22
EV/Sales
9.89
EV/EBIT
-5.58
EV/EBITDA
-5.68
EV/FCF
-5.17
Earnings Yield
-7.7%
FCF Yield
-16.4%
Adj. FCF Yield
-18.6%

Financial Health

Net Cash
$33.65M
Total Debt
$4.63M
Cash & Short-Term Investments
$38.27M
Total Assets
$62.39M
Current Ratio
6.46
Quick Ratio
5.31
Debt / Equity Ratio
0.15
Debt / EBITDA
-0.14
Debt / FCF
-0.13
OCF / Debt
-7.82
Interest Coverage
0.00
Altman Z-Score
3.22
Piotroski F-Score
4

Margins & Profitability

Gross Profit Margin
71.7%
Operating Profit Margin
-185.4%
EBITDA Margin
-176.3%
Net Profit Margin
-170.9%
FCF Margin
-191.3%
Adj. FCF Margin
-217.5%
SBC / Revenue
21.6%
SBC Impact (per share)
-13.7%

Returns

Return on Assets
-52.0%
Return on Equity
-62.5%
Return on Invested Capital
-60.5%
Return on Capital Employed
-65.7%
Return on Tangible Assets
-52.1%

Historical Growth (CAGR)

Revenue CAGR 3Y
33.6%
Revenue CAGR 5Y
15.1%
Revenue CAGR 10Y
19.1%
EPS CAGR 3Y
36.0%
EPS CAGR 5Y
15.8%
EPS CAGR 10Y
9.8%
FCF CAGR 3Y
-23.0%
FCF CAGR 5Y
-13.0%
FCF CAGR 10Y
-12.4%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
7
EPS Growth Next 3Y
83.7%
Revenue Growth Next 3Y
77.0%
Earnings Date
Nov 11, 2026
EPS Estimate (next Q)
-$0.23
EPS Growth Est (next Q)
-11.5%
Revenue Est (next Q)
$6.78M
Revenue Growth Est (next Q)
29.6%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$11
Price Target Upside
80.3%

Cash Flow

Operating Cash Flow
$-36.19M
Free Cash Flow
$-36.37M
Adj. Free Cash Flow
$-41.34M
FCF Per Share
-$0.98
OCF Per Share
-$0.98
OCF/S Ratio
-187.8%

Income Statement

Revenue
$19.01M
Gross Profit
$13.65M
Operating Income
$-35.26M
EBITDA
$-33.09M
Net Income
$-32.65M
EPS (Diluted)
-$0.47
Revenue / Employee
$117.36K
Profit / Employee
$-201.53K
Employees
162

© 2026 bestshares.com. All rights reserved.